In the News… Mounjaro update, CGM Medicare coverage shift, Metformin and aging study, Dolly Parton T1D connection and more!

On this episode of Diabetes Connections In the news… The FDA approves a new indication and health benefit for Mounjaro, lots of CGM news including an update on Medicare coverage for people who don’t use insulin and a new study about using CGM when you don’t have diabetes, metformin and aging, statins and type 2,…

In the News.. new weekly basal, retatrutide lawsuits, childhood T1D studies, run for T1D research and more!

On this episode of Diabetes Connections In the News…  A new basal insulin is available, researchers are working on a “cloak” designed to protect transplanted insulin-producing cells, Retatrutide isn’t even approved and it’s already the subject of lawsuits, tandem moves to pharmacy and more! Check out all of our events like Moms’ Night Out and Club…

In the News… Lantus Shortage, Pill for T1D Studied, Ring Measures Glucose in Sweat, Call Her Daddy Host Shares Diabetes Diagnosis, Cookie Queens Movie and more!

On this episode of Diabetes Connections In the news… Sanofi acknowledges an insulin shortage, a new oral therapy for type 1 moves along in research, could there be an actual, accurate, non-invasive CGM in the works, ADA conflict continues and a new documentary about Girl Scout cookies shines a spotlight on T1D. Don’t miss our…

In the News… More ADA Controversy, Insulin pricing bill, Setback for GLP-1 and T1D, Dexcom 15-day expands converage, and more!

On this episode of Diabetes Connections In the news… More accusations of censorship at the ADA, a setback for GLP1 medications for type 1, discussion of a federal insulin price cap, device news and mergers and and much more. Check out our fall in-person events: https://diabetes-connections.com/events/ Announcing Community Commericals! Learn how to get your message…

In the News… Tzield approved for newly diagnosed T1D, GLP-1 studies for type 1, ADA 2026 highlights and more!

It’s In The News – a look at the top diabetes stories and headlines happening now!   Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners – they help make the show possible! Omnipod – Simplify Life All about Dexcom …

In the News.. Inhaled Insulin Approved for Kids, CGM + Ketone Monitor, Food Coloring & Diabetes Study, Device Recalls and more!

It’s in the News! The top diabetes stories and headlines happening now. Top stories this week include: Afrezza inhaled Insulin is Approved for Kids, CGM + Ketone Monitor gets European approval, Food Coloring & Diabetes Study, Device Recalls include Omnipod and Dexcom, Beta Bionics shares more about their patch pump, ADA conference info and more!…

In the News.. Tzield approved for toddlers, generic Ozempic, Omnipod & Tandem updates, T1D Barbie honored… and more!

It’s In The News – where we bring you the top diabetes stories and headlines happening now. This week, Tzield approved down to age one and over, Omnipod trials for fully closed loop, Tandem approved for pregnancy, Eversense 365 launches in Europe, generic Ozempic in Canada, an award for the T1D Barbie and more.  Announcing…

In the News.. Stem Cell Research Update, New Patch Pump Approved, GLP-1 Resistance Studied, Big Win T1D School Kids and more!

It’s In the News! Every other week we bring you the top diabetes stories and headlines happening now. This week’s top stories: stem cell reserach updates, the Pivot patch pump gets FDA approval, GLP-1 Resistance research moves forward, T1D kids in VA get a big win, time of day for exercise matters, and much more!…

In the News… the “Next Ozempic” moves forward, diabetes and dementia link, tech updates & approvals, ATTD news and more

It’s In the News, a look at the top headlines and stories in the diabetes community. This week’s top stories: Metformin may help stem macular degeneration, retatutride moves forward, T1D and demntia link studied, lots of news from ATTD and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more…